The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
By Alexander E. Gorbalenya, S. Baker, Ralph S. Baric, R. D. de Groot, Christian Drosten, Anastasia A. Gulyaeva, B. Haagmans, C. Lauber, A. M. Leontovich, B. Neuman and 7 more. 2020
6,134 citations recorded by the source corpus.
The present outbreak of a coronavirus-associated acute respiratory disease called coronavirus disease 19 (COVID-19) is the third documented spillover of an animal coronavirus to humans in only two decades that has resulted in a major epidemic. The Coronaviridae Study Group (CSG) of the International Committee on Taxonomy of Viruses, which is responsible for developing the classification of viruses and taxon nomenclature of the family Coronaviridae, has assessed the placement of the human pathogen, tentatively named 2019-nCoV, within the Coronaviridae. Based on phylogeny, taxonomy and established practice, the CSG recognizes this virus as forming a sister clade to the prototype human and bat severe acute respiratory syndrome coronaviruses (SARS-CoVs) of the species Severe acute respiratory syndrome-related coronavirus, and designates it as SARS-CoV-2. In order to facilitate communication, the CSG proposes to use the following naming convention for individual isolates: SARS-CoV-2/host/location/isolate/date. While the full spectrum of clinical manifestations associated with SARS-CoV-2 infections in humans remains to be determined, the independent zoonotic transmission of SARS-CoV and SARS-CoV-2 highlights the need for studying viruses at the species level to complement research focused on individual pathogenic viruses of immediate significance. This will improve our understanding of virus–host interactions in an ever-changing environment and enhance our preparedness for future outbreaks.
Subfields: Animal Science and Zoology, Infectious Diseases
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Animal Science and Zoology
In Infectious Diseases
- A. Aschenbrenner
- Kwok-Yung Yuen
- Andrew G. Harrison
- Tao Lin
- Philippe Lemey
- Joachim L. Schultze
- Maciej F. Boni
- Andrew Rambaut
Citations in the corpus
- Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2 (2020, neutral): “In December 2019, a novel coronavirus (SARS-CoV-2) crossed species barriers to infect humans (Gorbalenya et al., 2020) and was effectively transmitted from person to person, leading to a pneumonia outbreak first reported in Wuhan, China (Guan et al., 2020; Jiang et al., 2020; Zhou et al., 2020b) .”
- Initial Challenges of Caregiving During COVID-19: Caregiver Burden, Mental Health, and the Parent–Child Relationship (2020, background): “COVID-19 is a novel, highly contagious but preventable disease caused by a coronavirus (SARS-CoV-2) [1], mortality rates for COVID-19 have surpassed 362,705 deaths worldwide and 103,700 deaths in the United States in May 2020, exceeding rates seen for other recent flu and SARS epidemics [2–4].”
- Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients (2020, background): “…Betacoronavirus, subgenus Sarbecovirus, family Coronaviridae, is a positive-polarity single-stranded RNA virus that probably originated in bats (Andersen et al., 2020; Lu et al., 2020; Gorbalenya et al., 2020) and is the causative agent of coronavirus disease of 2019 (COVID-19) (Li et al., 2020).”